CN116036218A - Shaolin ointment for treating rheumatism and traumatic injury - Google Patents

Shaolin ointment for treating rheumatism and traumatic injury Download PDF

Info

Publication number
CN116036218A
CN116036218A CN202310020909.2A CN202310020909A CN116036218A CN 116036218 A CN116036218 A CN 116036218A CN 202310020909 A CN202310020909 A CN 202310020909A CN 116036218 A CN116036218 A CN 116036218A
Authority
CN
China
Prior art keywords
root
common
cream
shaolin
traumatic injury
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310020909.2A
Other languages
Chinese (zh)
Inventor
张雯
于亮
李大伟
闫志猛
封静
赵爱丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Academy of Pharmaceutical Sciences
Original Assignee
Shandong Academy of Pharmaceutical Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Academy of Pharmaceutical Sciences filed Critical Shandong Academy of Pharmaceutical Sciences
Priority to CN202310020909.2A priority Critical patent/CN116036218A/en
Publication of CN116036218A publication Critical patent/CN116036218A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714Aconitum (monkshood)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/324Boswellia, e.g. frankincense
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/328Commiphora, e.g. mecca myrrh or balm of Gilead
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634Forsythia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/65Paeoniaceae (Peony family), e.g. Chinese peony
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/732Chaenomeles, e.g. flowering quince
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/889Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/898Orchidaceae (Orchid family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/902Sparganiaceae (Bur-reed family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to the technical field of traditional Chinese medicines, in particular to a composition and a preparation method of Shaolin rheumatism traumatic injury emulsifiable paste. The cream with the total prescription amount of 1000g comprises the following components: 50-80 g of clear paste, 30-50 g of fluid extract, 100-300 g of white vaseline, 20-150 g of paraffin, 0-200 g of stearic acid, 50-200 g of glyceryl monostearate, 50-200 g of glycerol polyethylene glycol-75 stearate, 8g of menthol, 8g of methyl salicylate, 8g of borneol, 0-50 g of glycerol, 1-5 g of preservative, 0.1-5 g of antioxidant and water, wherein the clear paste is prepared by water extraction of 16g of common monkshood mother root, 16g of raw kusnezoff monkshood root, 16g of combined spicebush root, 16g of common bletilla tuber, 16g of dahurian angelica root, 16g of Japanese ampelopsis root, 16g of ground beetle, 16g of common floweringquince fruit, 16g of common burreed rhizome, 16g of zedoary, 16g of Chinese angelica, 16g of red paeony root, 16g of cinnamon, 32g of rhubarb and 32g of weeping forsythiae capsule, and the fluid extract is prepared by alcohol extraction of 10g of dragon's blood, 6g of frankincense (stir-fried) 6g of myrrh, 6g of sanchi and 6g of catechu. Compared with the commercial Shaolin rheumatism and traumatic injury rubber paste, the Shaolin rheumatism and traumatic injury cream prepared by the invention has the advantages of more flexible coating amount, lower skin irritation, good stability and better curative effect.

Description

Shaolin ointment for treating rheumatism and traumatic injury
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a composition and a preparation method of Shaolin rheumatism traumatic injury emulsifiable paste.
Background
The shaolin rheumatism traumatic injury ointment is prepared from 22 traditional Chinese medicines such as raw radix aconiti, raw radix aconiti kusnezoffii, rheumatalgia, fructus forsythiae, pseudo-ginseng, menthol and the like, and methyl salicylate, and is mainly used for dispelling blood stasis and activating blood circulation, relaxing tendons and relieving pain, dispelling wind and dispelling cold, and is used for treating traumatic injury and rheumatalgia, wherein the symptoms are pain caused by stasis and swelling at the wounded part and lumbar limb numbness. The traditional commercial Shaolin rheumatism traumatic ointment is rubber ointment, rosin and other components contained in the prescription are adhered to the surface of skin for a long time to easily stimulate the skin, skin damage such as itching, erythema, edema or pimple is generated, partial patients are hard to feel skin damage, and local stuffiness is added after the plaster is adhered to the skin, so that skin inflammation is aggravated, the illness state of the original disease is covered, and treatment is delayed. In addition, the rubber paste has strong viscosity, physical pull injury is easily caused to human skin when the paste is uncovered, and the residual viscous substances on the surface of the human body are not easy to remove, so that the paste has small drug loading rate and long treatment course.
Disclosure of Invention
The invention aims to provide the shaolin rheumatism and traumatic injury cream which is easy to coat, flexible in coating amount, small in skin irritation, good in stability and good in curative effect.
The invention provides a Shaolin rheumatism and traumatic injury emulsifiable paste which is characterized in that the emulsifiable paste with the total prescription of 1000g comprises the following components: 50-80 g of clear paste, 30-50 g of fluid extract, 100-300 g of white vaseline, 20-150 g of paraffin, 0-200 g of stearic acid, 50-200 g of glyceryl monostearate, 50-200 g of glycerol polyethylene glycol-75 stearate, 8g of menthol, 8g of methyl salicylate, 8g of borneol, 0-50 g of glycerol, 1-5 g of preservative, 0.1-5 g of antioxidant and water, wherein the clear paste is prepared by water extraction of 16g of common monkshood mother root, 16g of raw kusnezoff monkshood root, 16g of combined spicebush root, 16g of common bletilla tuber, 16g of dahurian angelica root, 16g of Japanese ampelopsis root, 16g of ground beetle, 16g of common floweringquince fruit, 16g of common burreed rhizome, 16g of zedoary, 16g of Chinese angelica, 16g of red paeony root, 16g of cinnamon, 32g of rhubarb and 32g of weeping forsythiae capsule, and the fluid extract is prepared by alcohol extraction of 10g of dragon's blood, 6g of frankincense (stir-fried) 6g of myrrh, 6g of sanchi and 6g of catechu.
The invention provides a Shaolin ointment for treating rheumatism and traumatic injury, which is characterized in that a preservative is selected from any one of methylparaben and ethylparaben, and an antioxidant is selected from any one of dibutyl hydroxytoluene and propyl gallate.
The invention provides a preparation method of Shaolin rheumatism and traumatic injury cream, which is characterized in that the preparation method of the cream comprises the following steps:
1) Preparing clear paste: adding water which is 16g of common monkshood mother root, 16g of raw kusnezoff monkshood root, 16g of combined spicebush root, 16g of common bletilla tuber, 16g of dahurian angelica root, 16g of Japanese ampelopsis root, 16g of ground beetle, 16g of common floweringquince fruit, 16g of common burreed rhizome, 16g of zedoary, 16g of Chinese angelica, 16g of red paeony root, 16g of cassia bark, 32g of rhubarb, 32g of weeping forsythiae capsule and 6-8 times of the mass of the 15 medicinal materials into an extraction pot, heating for 3 hours to obtain dregs and primary liquid medicine, continuously adding water to carry out twice water extraction on the dregs for 3 hours and 2 hours respectively, mixing the liquid medicine obtained by the twice water extraction and the primary liquid medicine, and concentrating the liquid medicine under reduced pressure at 80 ℃ to obtain clear paste with the relative density of 1.25-1.30;
2) Preparing fluid extract: preparing 10g of dragon's blood, 6g of frankincense (stir-fried), 6g of myrrh (stir-fried), 6g of pseudo-ginseng and 6g of catechu into coarse powder in a pulverizer, and preparing a fluid extract with the relative density of 1.03-1.07 by 90% ethanol;
3) Preparing a emulsifiable paste: heating, melting and mixing the fluid extract, white vaseline, paraffin, stearic acid, glyceryl monostearate, glyceryl distearate, glycerol polyethylene glycol-75 stearate and antioxidant at 75-80 ℃ to obtain a phase I; heating menthol, borneol and methyl salicylate at 50-60 deg.c to mix homogeneously to form phase II; heating and mixing the clear paste, glycerol, preservative and water at 75-80 ℃ uniformly to obtain a phase III; adding phase II and phase III into phase I at 75-80 ℃, stirring and mixing uniformly at 2000-3000 rpm, and cooling to room temperature to form the cream.
Compared with the prior art, the invention has the following advantages: the self-made Shaolin rheumatism and traumatic injury cream effectively solves the problems that the air permeability of the commercial rubber cream is poor, sticky substances are easy to remain, pain, itching or physical strain of a patient are easy to occur when the cream is uncovered, allergic reactions such as erythema and edema are easy to occur on the skin, the drug loading rate is small, the course of treatment is long, the effect is slow, and the like in the use process, and the prepared cream is uniform and fine, easy to coat, flexible in coating amount, good in skin feel, easy to absorb, good in stability, low in irritation, curative effect, safety and better in patient medication compliance.
Detailed Description
Example preparation of Mirabilin ointment for treating rheumatism and traumatic injury
1.1 preparation of fluid extract
Weighing 16g of radix aconiti, 16g of raw kusnezoff monkshood root, 16g of combined spicebush root, 16g of rhizoma bletillae, 16g of dahurian angelica root, 16g of Japanese ampelopsis root, 16g of ground beetle, 16g of papaya, 16g of common burreed rhizome, 16g of zedoary, 16g of Chinese angelica, 16g of red paeony root, 16g of cinnamon, 32g of rhubarb, 32g of weeping forsythiae capsule and 1904g of water, heating for 3 hours to obtain dregs and primary liquid medicine, continuously adding 1088g of water, respectively carrying out water extraction for 3 hours and 2 hours twice, mixing the liquid medicine obtained by the water extraction for two times and the primary liquid medicine, concentrating under reduced pressure at 80 ℃ to obtain clear paste with the relative density of 1.25-1.30, wherein the amount of the clear paste is 67.3g.
1.2 preparation of fluid extract
Weighing 10g of dragon's blood, 6g of frankincense (stir-fried), 6g of myrrh (stir-fried), 6g of pseudo-ginseng and 6g of catechu, preparing coarse powder in a pulverizer, adding the coarse powder into an extraction pot, respectively adding 136g of 90% ethanol twice, respectively extracting for 3 hours under heating and refluxing, mixing the extracting solutions, filtering, and concentrating under reduced pressure at 70-80 ℃ to obtain fluid extract with the relative density of 1.03-1.07, wherein the fluid extract amount is 46.1g.
1.3 preparation of cream
1.3.1 emulsifier screening
Prescription composition:
Figure BDA0004042056240000021
/>
Figure BDA0004042056240000031
the preparation method comprises the following steps: weighing the liquid extract, white vaseline, paraffin, stearic acid, glyceryl monostearate, glyceryl polyethylene glycol-75 stearate or polyethylene glycol-7 stearate, and dibutyl hydroxytoluene with the formula amount, heating at 80deg.C, melting, and mixing to obtain phase I; heating menthol, borneol and methyl salicylate at 50-60 deg.c to mix homogeneously to form phase II; heating and mixing the fluid extract, polysorbate 80, glycerol, ethyl hydroxybenzoate and water at 80deg.C to obtain phase III; adding phase II and phase III into phase I at 80 ℃, stirring and mixing for 30min at 2200-2500 rpm, and cooling to room temperature to form the cream.
1.3.2 stability investigation
Cream samples 1 to 6 were prepared according to the recipe process listed in example one, and the stability of the samples under different conditions was examined, with the following results:
Figure BDA0004042056240000032
the results show that when the emulsifier selects glycerol polyethylene glycol-75 stearate, the stability of the cream is good and is obviously better than that of polyethylene glycol-7 stearate or polysorbate 80, and the glycerol polyethylene glycol-75 stearate is determined to be used as the emulsifier in self-made cream.
Example two skin irritation and allergy test
2.1 sample preparation and dosing
Figure BDA0004042056240000041
2.2 skin irritation test
Intact skin: experimental animals: guinea pigs, 300-400 g, male and female halves, are randomly divided into 4 groups of 10 animals each. The back and spine of each guinea pig were shaved symmetrically at two sides and each side was about 20cm in area prior to administration 2 24 hours after dehairing, it was examined whether the dehaired skin was injured, and if injured skin was not suitable for the test.
Dosing method and observations: the experiment adopts the comparison of the guinea pig body left and right, the left dehairing area respectively takes the cream 2 sample of the low dose, the medium dose and the high dose group and the rubber plaster of the commercial drug group, and the corresponding drug administration dose is evenly smeared or stuck on the left bare skin 19cm of the guinea pig 2 The blank cream samples of the blank group taken from the right side are uniformly smeared on the right naked skin 19cm of the guinea pig according to the corresponding administration dosage 2 As a control, administration was for 24 hoursAfter that, the plaster is removed, the residual medicine is removed by warm water, and the skin condition is observed and recorded at 1h, 24h, 48h and 72h after the medicine is removed.
Broken skin: experimental animals: guinea pigs, 300-400 g, male and female halves, are randomly divided into 4 groups of 10 animals each. The back and spine of each guinea pig were shaved symmetrically at two sides and each side was about 20cm in area prior to administration 2 24 hours after dehairing, it was examined whether the dehaired skin was injured, and if injured skin was not suitable for the test. The 7# syringe needle was used to scratch "#" type lesions on the haired skin of guinea pigs, and the same method as that of intact skin was immediately used for administration and observation until mild bleeding occurred in the skin.
Complete skin irritation results:
Figure BDA0004042056240000042
Figure BDA0004042056240000051
the results show that with intact skin administration, the self-made cream was almost free of skin irritation, the commercial rubber cream was slightly irritating, and after 3 days, some guinea pigs showed weak erythema.
Broken skin irritation results:
Figure BDA0004042056240000052
the results show that when the damaged skin is administrated, the self-made cream has no skin irritation in the middle-dose group and the low-dose group, the high-dose group has light skin irritation, the skin symptoms subside after 2 days, the commercial rubber paste has light to moderate irritation, part of guinea pig erythema still does not subside after 3 days, and the overall skin irritation of the self-made cream is superior to that of the commercial medicine.
2.3 skin allergy test
Experimental animals: guinea pigs, 300-400 g, male and female halves, are randomly divided into 6 groups of 10 animals each. Before administration at eachHairing is carried out on two symmetrical positions of the back spine of the guinea pig, and the area of each side is about 20cm 2 24 hours after dehairing, it was checked whether the dehaired skin was injured, e.g. injured skin was not suitable for testing.
Dosing method and observations:
sensitization contact: respectively taking low dose, medium dose, high dose, blank group of cream samples, commercially available drug group rubber plaster, and 1% positive control group of cream samples, and uniformly applying or pasting on the left side dehairing zone (19 cm) of guinea pig according to corresponding dosage 2 ) Drug removal was performed 6 hours after administration, and 1 and 3 times in the same manner were repeated for 7 days and 14 days.
Excitation contact: at 14 days after the final sensitization, respectively taking low dose, medium dose, high dose, blank group cream samples, commercially available medicine group rubber paste, 0.1% positive control group cream samples, and uniformly applying or pasting the cream samples on the right side dehairing zone (19 cm) of corresponding guinea pigs according to the corresponding administration dosage 2 ) After 6 hours, the medicines are removed, and the skin conditions are observed and recorded at 0h, 24h, 48h and 72h respectively.
Figure BDA0004042056240000061
The results showed that the positive control group had all allergic reactions (sensitization rate 100%), the self-made cream did not have allergic reactions (sensitization rate 0%) in the low, medium and high dose groups and the blank group, the sensitization rate was 50% in the commercial group, and the allergic reactions subsided after 3 days.
Example three self-made Shaolin rheumatism and Dieda cream treatment effect test
Test population: 50 volunteers with the age of 25-60 years and the body with bruises and pains are selected as trial subjects, wherein 22 men and 28 women are randomly divided into 2 groups of 25 persons.
Dosing method and observations: from pharmaceutical group: a shaolin rheumatism and traumatic injury cream sample was prepared by the method of example 2 at 1.87g/100cm 2 The administration dose of the medicine is uniformly smeared on the pain parts of the stasis and swelling on the volunteers, and the medicine is used for 3 days once a day; commercial drug group: a plaster containing xiaolin for treating rheumatism and traumatic injuryThe amount is as follows: 1.87g/100cm 2 ) Cutting into pieces, and applying onto the pain parts of volunteers with swelling and pain parts for 3 days. The administration areas from the pharmaceutical and commercial drug groups should cover the pain sites of the volunteers and the administration areas of both should be consistent. Both groups of volunteers self-described the effect of use and scored 3 days after dosing.
The scoring criteria and results were as follows:
Figure BDA0004042056240000062
Figure BDA0004042056240000071
group of Scoring results
Self-pharmacy group 4.4
Commercial medicine group 2.9
The results show that compared with the commercially available rubber paste, the self-made cream has better skin feel, quicker response, better curative effect and lower incidence of adverse reaction.

Claims (3)

1. A Shaolin ointment for treating rheumatism and traumatic injury is characterized in that the ointment with the total prescription of 1000g comprises the following components: 50-80 g of clear paste, 30-50 g of fluid extract, 100-300 g of white vaseline, 20-150 g of paraffin, 0-200 g of stearic acid, 50-200 g of glyceryl monostearate, 50-200 g of glycerol polyethylene glycol-75 stearate, 8g of menthol, 8g of methyl salicylate, 8g of borneol, 0-50 g of glycerol, 1-5 g of preservative, 0.1-5 g of antioxidant and water, wherein the clear paste is prepared by water extraction of 16g of common monkshood mother root, 16g of raw kusnezoff monkshood root, 16g of combined spicebush root, 16g of common bletilla tuber, 16g of dahurian angelica root, 16g of Japanese ampelopsis root, 16g of ground beetle, 16g of common floweringquince fruit, 16g of common burreed rhizome, 16g of zedoary, 16g of Chinese angelica, 16g of red paeony root, 16g of cinnamon, 32g of rhubarb and 32g of weeping forsythiae capsule, and the fluid extract is prepared by alcohol extraction of 10g of dragon's blood, 6g of frankincense (stir-fried) 6g of myrrh, 6g of sanchi and 6g of catechu.
2. The selinum rheumaticum traumatic injury cream according to claim 1, wherein the preservative is selected from any one of methylparaben and ethylparaben, and the antioxidant is selected from any one of dibutylhydroxytoluene and propyl gallate.
3. The shaolin rheumatism traumatic cream as claimed in claim 1, wherein the preparation method of the cream comprises the following steps:
1) Preparing clear paste: adding water which is 16g of common monkshood mother root, 16g of raw kusnezoff monkshood root, 16g of combined spicebush root, 16g of common bletilla tuber, 16g of dahurian angelica root, 16g of Japanese ampelopsis root, 16g of ground beetle, 16g of common floweringquince fruit, 16g of common burreed rhizome, 16g of zedoary, 16g of Chinese angelica, 16g of red paeony root, 16g of cassia bark, 32g of rhubarb, 32g of weeping forsythiae capsule and 6-8 times of the mass of the 15 medicinal materials into an extraction pot, heating for 3 hours to obtain dregs and primary liquid medicine, continuously adding water to carry out twice water extraction on the dregs for 3 hours and 2 hours respectively, mixing the liquid medicine obtained by the twice water extraction and the primary liquid medicine, and concentrating the liquid medicine under reduced pressure at 80 ℃ to obtain clear paste with the relative density of 1.25-1.30;
2) Preparing fluid extract: preparing 10g of dragon's blood, 6g of frankincense (stir-fried), 6g of myrrh (stir-fried), 6g of pseudo-ginseng and 6g of catechu into coarse powder in a pulverizer, and preparing a fluid extract with the relative density of 1.03-1.07 by 90% ethanol;
3) Preparing a emulsifiable paste: heating, melting and mixing the fluid extract, white vaseline, paraffin, stearic acid, glyceryl monostearate, glyceryl distearate, glycerol polyethylene glycol-75 stearate and antioxidant at 75-80 ℃ to obtain a phase I; heating menthol, borneol and methyl salicylate at 50-60 deg.c to mix homogeneously to form phase II; heating and mixing the clear paste, glycerol, preservative and water at 75-80 ℃ uniformly to obtain a phase III; adding phase II and phase III into phase I at 75-80 ℃, stirring and mixing uniformly at 2000-3000 rpm, and cooling to room temperature to form the cream.
CN202310020909.2A 2023-01-06 2023-01-06 Shaolin ointment for treating rheumatism and traumatic injury Pending CN116036218A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310020909.2A CN116036218A (en) 2023-01-06 2023-01-06 Shaolin ointment for treating rheumatism and traumatic injury

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310020909.2A CN116036218A (en) 2023-01-06 2023-01-06 Shaolin ointment for treating rheumatism and traumatic injury

Publications (1)

Publication Number Publication Date
CN116036218A true CN116036218A (en) 2023-05-02

Family

ID=86112807

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310020909.2A Pending CN116036218A (en) 2023-01-06 2023-01-06 Shaolin ointment for treating rheumatism and traumatic injury

Country Status (1)

Country Link
CN (1) CN116036218A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1306842A (en) * 2000-01-27 2001-08-08 哈尔滨太阳岛制药厂 Preparation of shaolin plaster for rheumatism and wound
CN107952035A (en) * 2017-12-04 2018-04-24 安徽金马药业有限公司 A kind of shaolin plaster for rheumatism and wound and production technology code
CN109833309A (en) * 2019-02-25 2019-06-04 山东省药学科学院 Memantine is sustained microplate capsule and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1306842A (en) * 2000-01-27 2001-08-08 哈尔滨太阳岛制药厂 Preparation of shaolin plaster for rheumatism and wound
CN107952035A (en) * 2017-12-04 2018-04-24 安徽金马药业有限公司 A kind of shaolin plaster for rheumatism and wound and production technology code
CN109833309A (en) * 2019-02-25 2019-06-04 山东省药学科学院 Memantine is sustained microplate capsule and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
王敏;等: "HPLC法测定少林风湿跌打膏中大黄素和大黄酚的含量", 海峡药学, vol. 28, no. 02, pages 87 - 88 *
王芳;等: "一种中药提取物的制备及对东莨菪碱模型小鼠学习记忆能力的影响", 药学研究, vol. 36, no. 03, pages 132 - 134 *

Similar Documents

Publication Publication Date Title
EP0606786B1 (en) A pharmaceutical composition for treating thermal injuries of warm blooded mammals and human
CN111281966B (en) Composition containing earthworm protein and preparation method and application thereof
CN103099844B (en) Traditional Chinese medicinal composition for treating infant eczema
CN108403932B (en) Traditional Chinese medicine compound external preparation for treating hormone-dependent dermatitis and preparation method and application thereof
CN110974861A (en) Blumea balsamifera oil liposome
CN110787261A (en) Ointment for clearing heat, cooling blood, stopping bleeding, relieving swelling and promoting wound healing and preparation method thereof
CN113599498B (en) Composite antibacterial peptide and preparation method thereof, and bee venom conditioning cream capable of quickly relieving pain and preparation method thereof
CN116036218A (en) Shaolin ointment for treating rheumatism and traumatic injury
CN101703667B (en) Brown red medicament for treating traumatic injuries and preparation method thereof
CN110812377B (en) Acne treatment and repair composition and application thereof
CN113244356A (en) Traditional Chinese medicine composition for treating psoriasis
CN116196381A (en) Emulsion for treating rheumatism and traumatic injuries
CN110507712B (en) Externally applied Chinese pulsatilla root extract for treating arthritis and preparation method thereof
CN113144115A (en) Traditional Chinese medicine composition for treating verruca vulgaris and application thereof
CN115463186B (en) Mongolian medicine emplastrum, preparation method and application thereof
CN114028487B (en) Pharmaceutical composition and preparation for treating acute soft tissue injury
US20200061144A1 (en) Composition and Method of Skin Relief Cream useful for Eczema, Psoriasis, Lipoma, Burn Wounds, Scars, Keloids, Shingles, Dry Skin Disorders, and Skin Allergies.
CN110664967B (en) Black plaster for softening hardness to dissipate stagnation, relieving swelling and pain and preparation process thereof
CN114028441B (en) Shenhuang ointment and preparation method and application thereof
CN113440590B (en) External toad stamen ointment for treating cancer pain
KR20200008289A (en) Herbal medicine composition for prevention and improvement of squama
CN103446306A (en) Application of active ingredient of external use Chinese patent medicine anti-cervical erosion suppository for treating gynecological diseases in medicines for treating tinea of hand and foot
CN115671239B (en) Anti-inflammatory, detumescence, antibacterial, antipruritic, anticracking and repairing jelly-curing cream and preparation method thereof
CN107714834A (en) A kind of composition of camellia oil preparation for external use, preparation method and applications
CN113995701B (en) Composition for removing acnes and acne marks as well as preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination